To explore the effects of cannabis use on anesthetic considerations, post-operative weight loss, complications, mortality, and psychiatric outcomes in bariatric patients, emphasizing the need for a multidisciplinary approach to management.
Key Findings:
Up to 25% of bariatric surgery patients do not achieve expected weight loss outcomes, highlighting the need for effective management strategies.
6-8% of bariatric patients admit to using cannabis, indicating a significant prevalence in this population.
Cannabis use is associated with increased peri-operative risks, including myocardial infarction and altered pulmonary function, necessitating careful monitoring.
Standardized guidelines for cannabis use in bariatric surgery are lacking, which complicates clinical decision-making.
Interpretation:
Cannabis use among bariatric patients poses unique challenges and risks that require careful consideration in perioperative management due to its effects on multiple organ systems.
Limitations:
Lack of standardized guidelines for cannabis use in bariatric surgery limits clinical practice.
Limited research on the long-term effects of cannabis in this specific patient population restricts understanding.
Variability in legal status and modes of cannabis use complicates management and patient education.
Conclusion:
A multidisciplinary approach is essential for managing cannabis use in bariatric patients to optimize surgical outcomes and minimize complications, reinforcing the importance of the proposed clinical pathway.
A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.
